Latest Breaking News On - Green room communications - Page 6 : comparemela.com

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023 - EyePoint Pharmaceuticals (NASDAQ:EYPT)

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal

United statesUniversity of massachusetts medical schoolJays dukerChristina tartagliaAmy phillipsDavidr lallyDavids boyerKeck school of medicineEyepoint pharmaceuticals incGreen room communicationsEquinox sciencesVitreous associates medical groupRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsPoint pharmaceuticalsChief executive officer

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of massachusetts medical schoolDavidr lallyDavids boyerJays dukerChristina tartagliaAmy phillipsEyepoint pharmaceuticals nasdaqKeck school of medicineRetinal surgeon at baystate medical centerEyepoint pharmaceuticalsEquinox sciencesVitreous associates medical groupGreen room communicationsEyepoint pharmaceuticals incPoint pharmaceuticals

EyePoint Pharmaceuticals Announces Presentations at Eyecelerator 2023, American Academy of Ophthalmology Annual Meeting 2023 and Guggenheim s 5th Annual Inflammation, Neurology & Immunology Conference 2023 -October 30, 2023 at 07:01 am EDT

WATERTOWN, Mass., Oct. 30, 2023 EyePoint Pharmaceuticals, Inc. , a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with retinal.

United statesChristina tartagliaAmy phillipsJays dukerAmerican academy of ophthalmologyEyepoint pharmaceuticals incGlobenewswire incPanel discussionGreen room communicationsEyepoint pharmaceuticalsEyepoint pharmaceuticals nasdaqPoint pharmaceuticalsChief executive officerAnnual meetingReceptor inhibitionTyrosine kinase inhibitor vorolanib

Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

/PRNewswire/ Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, recently shared findings from Mallinckrodt s latest health.

United statesDanielj specialePrnewswire mallinckrodtDerek belzDrug administrationAmerican college of chest physiciansSymphony healthOutcomes research onMallinckrodt pharmaceuticalsAcademy of managed care pharmacyNational institute of healthGreen room communicationsData sciencesExchange commissionNational institute of diabetesNephcure kidney international

EyePoint Pharmaceuticals to Report Third Quarter 2023

WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing.

United statesChristina tartagliaAmy phillipsEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsEyepoint pharmaceuticals incGreen room communicationsPoint pharmaceuticalsNasdaq eyptEyepoint pharmaceuticalsEyepoint pharma